Castle Biosciences Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon. Thanks for sticking around and joining us again at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson and I lead the medtech and diagnostics equity research team at Needham & Company.
I'm pleased to introduce Castle Biosciences. Presenting for Castle, we have CEO, Derek Maetzold; CFO, Frank Stokes; and Vice President, Investor Relations and Corporate Affairs, Camilla Zuckero. They're going to give a presentation on Castle and then we should have some time for questions for the end.
If you do have any questions that you would like to ask, you can submit them electronically through the Needham conference website or feel free to email them to me at [email protected], and I'll do my best to fit them.
So with that, I'll turn it over to Derek. Thanks.
Thank you, Mike, for introductions. It is a pleasure to join the Needham Healthcare Conference this year again. I've put together just a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |